AFP, BEIJING
Chinese developer Shimao Group Holdings Ltd (世茂集團) said it has failed to make payment on a US$1 billion bond that matured on Sunday, one of the biggest such defaults so far this year in the country’s troubled property sector.
China’s real-estate sector has been struggling since authorities began a crackdown on excessive debt and rampant consumer speculation in 2020, with giants such as China Evergrande Group (恆大集團) and Sunac China Holdings Ltd (融創中國) scrambling to make payments and renegotiate with creditors.
Photo: Reuters
The crisis has sparked fears that the industry’s struggles could spread to the wider economy, and the latest jolt came on Sunday when Shimao said it had not paid the principal and interest on a US$1 billion offshore note.
In a filing to the Hong Kong Stock Exchange, where it is listed, Shimao said it has experienced a noticeable decline in contracted sales due to “significant changes to the macro environment of the property sector in China since the second half of 2021 and the impact of COVID-19.”
The firm added that it had attempted to negotiate refinancing and waivers, but was unable to make some payments because of “challenging” market conditions.
It said it has not received notice from creditors for accelerated repayment and that lenders have indicated they would not take enforcement action at this point.
Shimao develops residential, hotel, office and commercial properties in China, with projects in major cities such as Beijing and Shanghai.
It was China’s 14th-biggest developer by contracted sales last year, according to Bloomberg News.
China’s developers have been struggling as homebuyers tightened their purse strings owing to an uncertain economic outlook.
One company in the eastern city of Nanjing said it would accept truckloads of watermelons as down payment from local farmers, Chinese media reported.
“The contagion has spread from Evergrande to Sunac and now Shimao,” Bloomberg Intelligence analyst Kristy Hung said. “That raises our concerns that the extent of the debt crisis is beyond any market watcher’s imagination.”
DATA SHOW DOWNTURN: Manufacturing in Taiwan contracted as production and demand slumped, while growth in chip exports last month eased in South Korea World chip sales growth has decelerated for six straight months in another sign that the global economy is straining under the weight of rising interest rates and mounting geopolitical risks. Semiconductor sales rose 13.3 percent in June from a year earlier, down from 18 percent in May, data from the global peak industry body showed. The slowdown is the longest since the US-China trade dispute in 2018. The three-month moving average in chip sales has correlated with the global economy’s performance in the past few decades. The latest weakness comes as concern about a worldwide recession has prompted chipmakers such as Samsung
Malaysia is scrambling to protect its assets as the descendants of the last sultan of the remote Philippine region of Sulu look to enforce a US$15 billion arbitration award in a dispute over a colonial-era land deal. In 1878, two European colonists signed a deal with the sultan for the use of his territory in present-day Malaysia — an agreement that independent Malaysia honored until 2013, paying the monarch’s descendants about US$1,000 per year. Now, 144 years later after the original deal, Malaysia is on the hook for the second-largest arbitration award on record for stopping the payments after a bloody incursion
RECOVERED CONFIDENCE: As market rationality returns, Taiwanese stocks that have lagged behind their US peers might soon catch up, Allianz researchers said Local shares last week defied heavy pressure from China’s military drills in waters around Taiwan, and investors this week are expected to pay attention to earnings results from several tech heavyweights as well as the latest economic data on exports and GDP. The TAIEX closed at 15,036.04 points on Friday, posting a weekly increase of 0.24 percent from 15,000.07 on July 29, Taiwan Stock Exchange data showed. Over the same period, the FTSE TWSE Taiwan 50 Index, which comprises Taiwan’s top 50 stocks in terms of market capitalization, closed up 0.93 percent at 11,750.15 points, while the Formosa Stock Index, which measures
Pharmaceutical start-up AcadeMab Biomedical Inc (研生生醫) said it has been developing a COVID-19 antibody drug, an endeavor not being undertaken by many other Taiwanese pharmaceutical firms. The company was spun off from Academia Sinica’s Institute of Cellular and Organismic Biology in 2020 and has only 16 employees. It has set its sights on the innovative field of the monoclonal antibody treatment of tumors. The start-up began developing antibody drugs in January, after seeing that COVID-19 vaccines could not effectively protect people from new variants of SARS-CoV-2, AcadeMab Biomedical chief strategy officer Pearl Fong (俸清珠) said in an interview with the Taipei Times
RSS